相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy
Sandra Bien et al.
CANCER RESEARCH (2007)
Bcl-2-regulated apoptosis: mechanism and therapeutic potential
Jerry M. Adams et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Mitochondrial and nuclear p53 localization in cardiomyocytes: Redox modulation by doxorubicin (adriamycin)?
Ramaneeya Nithipongvanitch et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Doxorubicin degradation in cardiomyocytes
Pierantonio Menna et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Phosphorylation,of p53 at serine 15 in A549 pulmonary epithelial cells exposed to vanadate: Involvement of ATM pathway
Katsura Suzuki et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
DNA damage is an early event in doxorubicin-induced cardiac myocyte death
Thomas L'Ecuyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: Novel cellular mechanisms involving the ERKs/p53 cascade
Moussa Alkhalaf et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis
M. Jiang et al.
ONCOGENE (2006)
Involvement of the extracellular signal-regulated protein kinase pathway in phosphorylation of p53 protein and exerting cytotoxicity in human neuroblastoma cells (SH-SY5Y) exposed to acrylamide
T Okuno et al.
ARCHIVES OF TOXICOLOGY (2006)
The involvement of MAPK signaling pathways in determining the cellular response to p53 activation - Cell cycle arrest or apoptosis
L Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase
P Spallarossa et al.
CARDIOVASCULAR RESEARCH (2006)
Multiple actions of pifithrin-alpha on doxorubicin- induced apoptosis in rat myoblastic H9c2 cells
Chu Chang Chua et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells
YK Kim et al.
JOURNAL OF APPLIED TOXICOLOGY (2005)
The transcriptional targets of p53 in apoptosis control
J Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Stress-induced p53 runs a transcription-independent death program
S Erster et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice
Y Shizukuda et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy
H Lou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice
XW Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Cell death: Critical control points
NN Danial et al.
CELL (2004)
Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation
S Schweyer et al.
BRITISH JOURNAL OF CANCER (2004)
The pathophysiology of mitochondrial cell death
DR Green et al.
SCIENCE (2004)
Post-translational modification of p53 in tumorigenesis
AM Bode et al.
NATURE REVIEWS CANCER (2004)
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways
JR Jeffers et al.
CANCER CELL (2003)
Suppression of high-fidelity double-strand break repair in mammalian chromosomes by pifithrin-α, a chemical inhibitor of p53
YF Lin et al.
DNA REPAIR (2003)
The BCL2 family: Regulators of the cellular life-or-death switch
S Cory et al.
NATURE REVIEWS CANCER (2002)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
Peak plasma concentrations of doxorubicin in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma
G Hempel et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
G Pearson et al.
ENDOCRINE REVIEWS (2001)
PUMA, a novel proapoptotic gene, is induced by p53
K Nakano et al.
MOLECULAR CELL (2001)
Requirement for ERK activation in cisplatin-induced apoptosis
XT Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The DNA damage response: putting checkpoints in perspective
BBS Zhou et al.
NATURE (2000)
Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin
DL Persons et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation
QB She et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases
YJ Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Adriamycin-induced heart failure: mechanisms and modulation
P Singal et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)